Development of a Novel Methodology Using BMVC Staining as an Assistance to Cancer Cytological Diagnosis

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2011 by Far Eastern Memorial Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Li-Jen Liao, Far Eastern Memorial Hospital
ClinicalTrials.gov Identifier:
NCT01301690
First received: February 21, 2011
Last updated: September 16, 2011
Last verified: September 2011
  Purpose

3,6-bis(1-methyl-4-vinylpyridinium) carbazole diiodide (BMVC) is an inorganic chemical compound (Figure1). The uptake of BMVC in cancer cells and normal cells are different. Recently, a simple handheld device (Figure1) based on the fluorescence analysis of stained cells was established to instantly differentiate cancer cells from normal cells. The investigators want to quantitatively measure the fluorescence expression of BMVC in normal and cancer cells and explore the usefulness of this staining in head and neck lumps.


Condition
Neck Mass

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Far Eastern Memorial Hospital:

Estimated Enrollment: 100
Study Start Date: January 2010
Groups/Cohorts
Neck masses
Neck mass received US and US-FNA

  Eligibility

Ages Eligible for Study:   18 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

We propose to collect consecutive patients (age range from 18 to 90 years old) with neck lumps, receiving sonographic examination and FNA cytologic study.

Criteria

Inclusion Criteria:

  • patients (age range from 18 to 90 years old) with neck lumps, receiving sonographic examination and FNA cytologic study.

Exclusion Criteria:

  • No cytology data
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01301690

Contacts
Contact: Li-Jen Liao, MD +886-0-8967-1592 deniro@mail2000.com.tw

Locations
Taiwan
Department of Otolaryngology Far Eastern Memorial Hospital Recruiting
Taipei, Taiwan
Contact: Shih-Hong Huang, M.D., Ph.D.    +886 0 89671592    irb@mail.femh.org.tw   
Sponsors and Collaborators
Far Eastern Memorial Hospital
Investigators
Study Director: Li-Jen Liao, MD Department of Otolaryngology Far Eastern Memorial Hospital, Taipei, Taiwan
  More Information

Publications:
Responsible Party: Li-Jen Liao, Department of Otolaryngology, Far Eastern Memorial Hospital
ClinicalTrials.gov Identifier: NCT01301690     History of Changes
Other Study ID Numbers: FEMH No.:98041-3
Study First Received: February 21, 2011
Last Updated: September 16, 2011
Health Authority: Taiwan: Department of Health

Keywords provided by Far Eastern Memorial Hospital:
neck mass
ultrasound
FNA
BMVC

ClinicalTrials.gov processed this record on July 24, 2014